Form 4: Baker Bros. Advisors Increase Stake in KALA BIO, Inc. Through Private Placement

Baker Bros. Advisors LP and related entities acquired additional shares of KALA BIO, Inc. common stock through a private placement, increasing their beneficial ownership.

Summary

• Baker Bros. Advisors LP and affiliated entities, including Baker Biotech Capital, L.P. and Baker Brothers Life Sciences, L.P., increased their stake in KALA BIO, Inc.
• On December 30, 2024, the Funds purchased 30,620 and 279,939 shares of common stock of KALA BIO, Inc., respectively, for $6.44 per share.
• The purchases were made through a private placement with the Issuer that closed on December 31, 2024.
• Following the transaction, the total number of shares beneficially owned indirectly by 667, L.P. is 118,496.
• Following the transaction, the total number of shares beneficially owned indirectly by Baker Brothers Life Sciences, L.P. is 1,083,398.
• Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the shares held by the Funds due to their ownership interests in the related entities.
• Baker Bros. Advisors LP serves as the investment advisor to the Funds and has complete discretion over investment and voting power.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Increased investment by a major shareholder is generally viewed favorably, but the filing itself is a routine disclosure.

Positives

• Increased investment by a significant shareholder like Baker Bros. Advisors could be seen as a positive signal for the company's prospects.
• The private placement provides KALA BIO, Inc. with additional capital.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares. This filing indicates increased investment by a major shareholder, which is often monitored by the market for signals about the company's future prospects.

Stakeholder Impact

• Shareholders may view the increased investment positively.
• The company benefits from the additional capital raised through the private placement.

Key Dates